WIM
DNLI icon

Westside Investment Management’s Denali Therapeutics DNLI Stock Holding History

Westside Investment Management’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33
Closed -$545 – 1490
2025
Q4 		$545 Buy
+33
New +$557 ﹤0.01% 1428

Other funds holding DNLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Westside Investment Management's DNLI Position: Q1 2026 in Review

Westside Investment Management sold out of Denali Therapeutics (DNLI) in Q1 2026, closing a stake of 33 shares — an estimated $545 sold.

Westside Investment Management first reported a position in DNLI in Q4 2025 and held it in 1 quarter. The position peaked at $545 in Q4 2025. 269 funds tracked by Wall St. Rank hold DNLI as of Q1 2026.

  • Westside Investment Management reported no remaining Denali Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Westside Investment Management sold 33 Denali Therapeutics shares in Q1 2026, an estimated $545.
  • Westside Investment Management first reported a position in Denali Therapeutics in Q4 2025 and held it in 1 quarter.
  • Westside Investment Management's Denali Therapeutics position peaked at $545 in Q4 2025.
  • 269 funds tracked by Wall St. Rank held Denali Therapeutics as of Q1 2026.

Based on Westside Investment Management's 13F filing for Q1 2026, filed 4 May 2026.